• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状旁腺功能亢进:复发性钙肾结石的原因还是结果?

Hyperparathyroidism: cause or consequence of recurrent calcium nephrolithiasis?

作者信息

D'Angelo A, Lodetti M G, Giannini S, Castrignano R, al Awady M, Malvasi L, Fabris A, Maschio G

机构信息

Institute of Internal Medicine, University of Padova, Italy.

出版信息

Miner Electrolyte Metab. 1992;18(6):359-64.

PMID:1291857
Abstract

Primary hyperparathyroidism (PHP) might be characterized by either prevailing bone or renal stone patterns with different metabolic features. To explore the possibility of different hormonal patterns we studied 129 patients with PHP: 95 stone formers (SF) and 34 nonstone formers (NSF). Females prevailed over males in both groups. Severe and specific bone lesions were more evident in NSF than SF. Parathyroid gland histology displayed a prevalence of adenoma in NSF, whereas isolated hyperplasia prevailed in SF. SF had lower levels of serum Ca, urinary Ca, ALP and serum PTH than NSF. As expected serum 1,25-dihydroxyvitamin D [1,25(OH)2 D] levels were greater in both groups of patients than in controls but we found no difference between the two groups. 25-Hydroxyvitamin D was neither increased with respect to controls nor different between groups. We conclude that patients with PHP may represent well separated metabolic and clinical entities, but we cannot confirm that serum 1,25(OH)2D levels play a key role in discriminating the different clinical features. In addition, the findings of predominant parathyroid hyperplasia in SF and the clinical evidence of recurrent hyperparathyroidism only in these patients suggest the possibility that the endocrine disorder might be the consequence over time rather than the cause of nephrolithiasis.

摘要

原发性甲状旁腺功能亢进症(PHP)可能以占主导的骨型或肾结石型伴不同代谢特征为特点。为探究不同激素模式的可能性,我们研究了129例PHP患者:95例肾结石患者(SF)和34例无肾结石患者(NSF)。两组中女性均多于男性。NSF组中严重且特殊的骨病变比SF组更明显。甲状旁腺组织学显示NSF组中腺瘤占比更高,而SF组中孤立性增生占主导。SF组的血清钙、尿钙、碱性磷酸酶(ALP)和血清甲状旁腺激素(PTH)水平低于NSF组。正如预期的那样,两组患者的血清1,25 - 二羟维生素D [1,25(OH)₂D]水平均高于对照组,但我们发现两组之间无差异。25 - 羟维生素D相对于对照组既未升高,两组之间也无差异。我们得出结论,PHP患者可能代表代谢和临床特征截然不同的两类人群,但我们无法证实血清1,25(OH)₂D水平在区分不同临床特征方面起关键作用。此外,SF组中甲状旁腺增生占主导的发现以及仅在这些患者中出现复发性甲状旁腺功能亢进的临床证据表明,随着时间推移,这种内分泌紊乱可能是肾结石的后果而非原因。

相似文献

1
Hyperparathyroidism: cause or consequence of recurrent calcium nephrolithiasis?甲状旁腺功能亢进:复发性钙肾结石的原因还是结果?
Miner Electrolyte Metab. 1992;18(6):359-64.
2
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
3
Circulating concentrations of 1,25-dihydroxyvitamin D3 in patients with primary hyperparathyroidism.原发性甲状旁腺功能亢进患者循环中1,25 - 二羟维生素D3的浓度。
Bone Miner. 1986 Apr;1(2):137-44.
4
Does the plasma concentration of 25-hydroxyvitamin D determine the level of 1,25-dihydroxyvitamin D in primary hyperparathyroidism?在原发性甲状旁腺功能亢进症中,25-羟基维生素D的血浆浓度是否决定1,25-二羟基维生素D的水平?
Miner Electrolyte Metab. 1996;22(4):203-6.
5
[Nephrolithiasis and bone involvement in primary hyperparathyroidism. The relative role of vitamin D].原发性甲状旁腺功能亢进症中的肾结石与骨骼受累。维生素D的相对作用
Rev Clin Esp. 1992 Mar;190(5):238-42.
6
Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.原发性甲状旁腺功能亢进症患者的血浆1,25-二羟维生素D水平取决于性别、体重指数、血浆磷酸盐和肾功能。
Clin Endocrinol (Oxf). 2007 Jan;66(1):35-42. doi: 10.1111/j.1365-2265.2006.02680.x.
7
Clinical and biochemical patterns of presentation in monolateral and bilateral calcium nephrolithiasis.单侧和双侧钙性肾结石的临床及生化表现模式
Clin Nephrol. 1997 Jan;47(1):23-7.
8
Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism.伴有和不伴有原发性甲状旁腺功能亢进的钙结石形成者的临床和实验室特征。
BJU Int. 2009 Mar;103(5):670-8. doi: 10.1111/j.1464-410X.2008.08064.x. Epub 2008 Sep 12.
9
Interrelationships between circulating vitamin D metabolites in normocalciuric and hypercalciuric renal stone formers.正常钙尿症和高钙尿症肾结石患者循环维生素D代谢物之间的相互关系。
Ann Nutr Metab. 1985;29(5):289-96. doi: 10.1159/000176984.
10
Clinical effects of parathyroid surgery in normocalcaemic patients with recurrent renal stones.甲状旁腺手术对血钙正常的复发性肾结石患者的临床疗效
Acta Chir Scand. 1980;146(3):161-9.

引用本文的文献

1
Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism.维生素D缺乏对散发性原发性甲状旁腺功能亢进症女性临床及生化表型的影响。
Endocrine. 2017 Jan;55(1):256-265. doi: 10.1007/s12020-016-0931-8. Epub 2016 Mar 31.
2
Hypercalcemic States associated with nephrolithiasis.与肾结石相关的高钙血症状态
Rev Urol. 2008 Summer;10(3):218-26.
3
Biochemical characterization of primary hyperparathyroidism with and without kidney stones.伴或不伴肾结石的原发性甲状旁腺功能亢进症的生化特征
Urol Res. 2007 Jun;35(3):123-8. doi: 10.1007/s00240-007-0096-2. Epub 2007 May 3.
4
Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study.甲状旁腺手术前后原发性甲状旁腺功能亢进症患者发生肾结石事件的风险:对照性回顾性随访研究
BMJ. 2002 Oct 12;325(7368):807. doi: 10.1136/bmj.325.7368.807.
5
The cause of maintained hypercalciuria after the surgical cure of primary hyperparathyroidism is a defect in renal calcium reabsorption.原发性甲状旁腺功能亢进症手术治愈后持续高钙尿症的原因是肾钙重吸收缺陷。
J Endocrinol Invest. 1996 Jan;19(1):12-20. doi: 10.1007/BF03347852.